Six Slinn Picks – chemical news

  • Device proves solar cell potential of high bandgap inorganic nanowire arrays – A report, published in the March 14 edition of the Journal of Materials Chemistry, announced the successful fabrication and testing of a new type solar cell using an inorganic core/shell nanowire structure.
  • Diabetes drug could treat breast cancer, say scientists – A drug routinely used by thousands of diabetics could play a part in fighting breast cancer, research suggests. Scientists in Manchester have developed a new test to identify patients with aggressive forms of the disease who could benefit from Metformin.
  • New frontiers in the search for novel, noninvasive biomarkers – The one-size-fits-all approach to therapies is quickly becoming a thing of the past, as drug developers begin stepping up to the challenge of personalized medicine, and regulatory agencies scramble to keep up. As the search for new biological indicators of disease heats up, researchers are looking far and wide for new markers of disease and of response to treatment.
  • World’s first human brain map unveiled – The world's first computerised map of the brain was released yesterday by scientists at the Allen Institute for Brain Science, in Seattle, Washington, after more than four years of cutting-edge research.
  • Researchers unlock clue to personalized cancer medicine using tumor metabolism – Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any type of human cancer cell.
  • Microrockets aim at cancer diagnostics – Researchers at the University of California, San Diego, have made self-propelled microtube rockets that can find and capture cancer cells from blood samples.

Chemist and writer Robert Slinn picks six of the best for his regular web column on Reactive Reports – Slinn Pickings.